A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
By John G. Csernansky, R. Mahmoud, R. Brenner. New England Journal of Medicine, 2002
644 citations recorded by the source corpus.
Subfields: Clinical Psychology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/522e423ca7d976452f217fdb1a8dd5ecd9ccbd25
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Clinical Psychology
In Psychiatry and Mental health
Citations in the corpus
- Relapse prediction in schizophrenia through digital phenotyping: a pilot study (2018, background): “We defined clinical relapse as either psychiatric hospitalization or an increase in the level of psychiatric care, such as increase in the frequency of clinic visits or referral to a partial or outpatient hospital program [21].”
- Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. (2005, neutral): “All others 52 (15) 58 (17) 60 (18) 30 (11) 29 (16) 229 (16)”